Andrew Proudfoot

No ORCID on file · 7 papers in corpus · active 2022-2025

Study types

  • preprint 3
  • article 2
  • other 1

Condition tags

  • endometriosis 6
  • dysmenorrhea 2
  • chronic_pelvic_pain 1
preprint 2025
“A dose of relief?”: Results of an international survey exploring self-reported effectiveness, dose and dosage forms of cannabis for endometriosis pain and related symptoms
·doi:10.21203/rs.3.rs-6910005/v1

Abstract Background Endometriosis is a common, chronic inflammatory condition impacting 10–14% of reproductive aged females. Common symptoms include severe dysmenorrhea, pelvic pain and fatigue. Current symptom management options are often…

preprint 2025
Damned if you do, damned if you don’t? Misrepresentation and fraudulent non-disclosure consequences of Australians with endometriosis not disclosing cannabis use to life insurers.
·doi:10.31219/osf.io/23ys9_v1

People with endometriosis in Australia predominantly use delta-9 tetrahydrocannabinol cannabis flower and oil products, and cannabidiol preparations, to manage their symptoms, reporting reductions in use of other drugs. It is known that low…

preprint 2025
Insurance, Endometriosis and the use of medicinal cannabis in Australia: A qualitative analysis
·doi:10.21203/rs.3.rs-6083910/v1

Abstract Background Endometriosis is a complex multi-systemic disease that costs Australia $9.7Bill per annum, 84% of this cost is workplace absenteeism and lost productivity. Public insurance coverage via Medicare is limited, so access to…

article 2024
A survey of cost, access and outcomes for cannabinoid-based medicinal product use by Australians with endometriosis
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.13804

People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self-reported effectiveness for those accessing medicinal cannabis in Australia. There we…

article 2023
The Place of Cannabinoids in the Treatment of Gynecological Pain
Drugs ·doi:10.1007/s40265-023-01951-z

Cannabis sativa (L), a plant with an extensive history of medicinal usage across numerous cultures, has received increased attention over recent years for its therapeutic potential for gynecological disorders such as endometriosis, chronic …

other 2022
Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey
Cannabis and cannabinoid research ·doi:10.1089/can.2021.0162

Introduction: Endometriosis affects 1 in 10 women worldwide, with most experiencing difficulties achieving adequate symptom control. These difficulties have been compounded by the onset of the COVID-19 pandemic due to worldwide shifts in he…

2022
"Should I Inhale?"-Perceptions, Barriers, and Drivers for Medicinal Cannabis Use amongst Australian Women with Primary Dysmenorrhoea: A Qualitative Study.
International journal of environmental research and public health ·doi:10.3390/ijerph19031536

ObjectiveThis study sought to investigate the perceptions, barriers, and drivers associated with medicinal cannabis use among Australian women with primary dysmenorrhea. A qualitative study via virtual focus groups involving 26 women experi…